Authors: Fazekas, F Strasser-Fuchs, S Kollegger, H Berger, T Kristoferitsch, W Schmidt, H Enzinger, C Schiefermeier, M Schwarz, C Kornek, B Reindl, M Huber, K Grass, R Wimmer, G Vass, K Pfeiffer, KH Hartung, HP Schmidt, R

Citation: F. Fazekas et al., Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis, NEUROLOGY, 57(5), 2001, pp. 853-857

Authors: Buttner, U Chofflon, M Hess, K Kappos, L Kesselring, J Ludin, HP Schluep, M Vaney, C Baumhackl, U Berger, T Deisenhammer, F Freimuller, M Hartung, HP Kollegger, H Kristoferitsch, W Lassmann, H Markut, H Vass, K Altenkirch, H Boese, J Gass, A Gehlen, W Goebels, N Haas, J Haferkamp, G Heidenreich, F Heitmann, R Hemmer, B Hohlfeld, R Janzen, RWC Jugelt, E Kolmel, W Konig, N Kowitzsch, K Manegold, U Melms, A Mertin, J Petereit, HF Pette, M Pohlau, D Poser, S Sailer, M Schmidt, S Schock, G Schulz, M Seidel, D Stangel, M Stark, E Stoll, G Weinrich, W Wietholter, H Zettl, UK Zipp, F Zschenderlein, R Bayas, A Chan, A Flachenecker, P Gold, R Grauer, O Jung, S Kallmann, B Leussink, V Maurer, M Rieckmann, P Toyka, KV Weilbach, FX

Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement, NERVENARZT, 72(2), 2001, pp. 150-157

Authors: Schiefermeier, M Kollegger, H Madl, C Schwarz, C Holzer, M Kofler, J Sterz, F

Citation: M. Schiefermeier et al., Apolipoprotein E polymorphism - Survival and neurological outcome after cardiopulmonary resuscitation, STROKE, 31(9), 2000, pp. 2068-2073

Authors: Gerschlager, W Beisteiner, R Deecke, L Dirnberger, G Endl, W Kollegger, H Lindinger, G Vass, K Lang, W

Citation: W. Gerschlager et al., Electrophysiological. neuropsychological and clinical findings in multiplesclerosis patients receiving interferon beta-1b: A 1-year follow-up, EUR NEUROL, 44(4), 2000, pp. 205-209

Authors: Schiefermeier, M Kollegger, H Madl, C Polli, C Oder, W Kuhn, HJ Berr, F Ferenci, P

Citation: M. Schiefermeier et al., The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease, BRAIN, 123, 2000, pp. 585-590

Authors: Kollegger, H Schmied, M Zebenholzer, K Zeiler, K Hittmair, K Mallek, R

Citation: H. Kollegger et al., Vaccinations and steroids in MS: effects on disease progression and mood, ACT NEUR SC, 100(1), 1999, pp. 69-73